First-in-human phase I study of givastomig, a novel Claudin 18.2/4-1BB bispecific antibody in advanced solid tumors Meeting Abstract


Authors: Ku, G.; Shen, L.; Klempner, S. J.; Pan, H.; Kratz, J.; Liang, X.; Deng, Y.; Kim, S.; Wang, Z.; Feller, L.; Powderly, J.; Dayyani, F.; Schneider, R. E.; Girda, E.; Berlin, J. D.; Spencer, K.; Nguyen, M. T.; Wang, V.; Xu, C.; Zhu, A.
Abstract Title: First-in-human phase I study of givastomig, a novel Claudin 18.2/4-1BB bispecific antibody in advanced solid tumors
Meeting Title: ESMO Congress 2023
Journal Title: Annals of Oncology
Volume: 34
Issue: Suppl. 2
Meeting Dates: 2023 Oct 20-24
Meeting Location: Madrid, Spain
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2023-10-01
Start Page: S631
Language: English
ACCESSION: WOS:001087480201369
DOI: 10.1016/j.annonc.2023.09.2178
PROVIDER: wos
Notes: Meeting Abstract: 1039P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Geoffrey Yuyat Ku
    230 Ku